Prognostic Role of Interferon-λ3 in Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis-Associated Interstitial Lung Disease.
Atsuki FukadaTomoyuki FujisawaHironao HozumiKeigo KodaTaisuke AkamatsuYoshiyuki OyamaYasuomi SatakeMitsuru NiwaYusuke KaidaHiroyuki MatsudaKoshi YokomuraNaoki KoshimizuMikio ToyoshimaShiro ImokawaDai HashimotoAkira YoshidaTakahisa GonoMasataka KuwanaYasuhiko YamanoYasuhiro KondohKeita YamashitaMasato MaekawaKazutaka MoriYusuke InoueHideki YasuiYuzo SuzukiMasato KarayamaKazuki FuruhashiNoriyuki EnomotoNaoki InuiTakafumi SudaPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2023)
Serum IFNλ3 is a promising biomarker for identifying patients at high risk of poor outcomes in anti-MDA5 antibody-positive DM-ILD.
Keyphrases
- interstitial lung disease
- systemic sclerosis
- rheumatoid arthritis
- idiopathic pulmonary fibrosis
- end stage renal disease
- ejection fraction
- dendritic cells
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- immune response
- prognostic factors
- type diabetes
- genome wide
- cell proliferation
- cell death
- glycemic control
- patient reported
- cell cycle arrest